Vivos (RDGL) Net Income Growth (3y) (2013 - 2025)
Vivos (RDGL) Net Income Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 280.49% |
| 10 | Vivos | 27.62 Mn | 26.06 Mn | -3,105.00 | -15.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.19% |
| Sep 30, 2025 | -22.34% |
| Jun 30, 2025 | 6.41% |
| Mar 31, 2025 | -6.05% |
| Dec 31, 2024 | -79.06% |
| Sep 30, 2024 | -60.08% |
| Jun 30, 2024 | 35.32% |
| Mar 31, 2024 | -24.68% |
| Dec 31, 2023 | -52.73% |
| Sep 30, 2023 | -70.13% |
| Jun 30, 2023 | -78.35% |
| Mar 31, 2023 | 11.66% |
| Dec 31, 2022 | -11.87% |
| Sep 30, 2022 | 25.47% |
| Jun 30, 2022 | -57.83% |
| Mar 31, 2022 | -43.60% |
| Dec 31, 2021 | -26.14% |
| Sep 30, 2021 | 80.45% |
| Jun 30, 2021 | 32.36% |
| Mar 31, 2021 | 31.62% |